FLUOKSETİN VE DÜŞÜK DOZ TRAZODONUN BİRLİKTE KULLANIMIYLA OLASI SEROTONİN SENDROMU DÜŞÜNDÜREN VE NARANJO İLAÇ YAN ETKİSİ OLASILIĞI ÖLÇEĞİ İLE DEĞERLENDİRİLEN BİR OLGU

Öz

Serotonin sendromu serotonerjik ajan kullanımı sonrasında oluşan serotonin reseptörlerinin aşırı uyarılması sonucu gelişen nadir görülen fakat mortal seyredebilen sendromdur. Klinik belirti ve bulgular kognitif, nöromüsküler ve otonomik alanda görülmektedir. Serotonerjik etkili bir veya daha fazla ajanın birlikte kullanılması bu sendroma neden olur. Klinik görünümü hafif şiddette olup gözden kaçabilen olgular olduğu gibi hayatı tehdit eden, yoğun bakım ve mekanik ventilasyon gerektiren şiddette de olabilmektedir. Bu yazıda fluoksetin tedavisine trazodon eklenmesi ve doz artırılması sonrasında 24 saat içerisinde gelişen serotonin sendromu düşündüren bir vaka sunulmuştur.

Anahtar Kelimeler

• Fluoksetin
• Serotonin sendromu
• Trazodon

A CASE POSSIBLE SEROTONIN SYNDROME CASE CAUSED BY COMBINED USE OF FLUOXETINE AND LOW DOSE TRAZODONE AND ASSESSED BY THE NARANJO ADVERSE DRUG REACTION PROBABILITY SCALE

Öz

Serotonin syndrome is a rare but life-threatening syndrome that develops as a result of excessive stimulation of serotonin receptors after the use of serotonergic agents. Clinical signs and symptoms are seen in the cognitive, neuromuscular and autonomic areas. Combination of one or more drugs with serotonergic effect causes this syndrome. While there are cases with a mild clinical appearance that can be overlooked, they can also be life-threatening and require intensive care and mechanical ventilation. In this article, a case of serotonin syndrome, which developed within 24 hours after adding trazodone to fluoxetine treatment and increasing the dose, was presented.

Anahtar Kelimeler

• serotonin syndrome
• trazodone
• fluoxetine

Kaynakça

1. 1. Scotton WJ, Hill LJ, Williams AC, Barnes NM. Serotonin syndrome: pathophysiology, clinical features, management, and potential future directions. International Journal of Tryptophan Research. 2019;12:1178646919873925.
2. 2. Özdemir S, Kocabaşoǧlu N. Serotonin Sendromuna Güncel Bir Yaklaşım. Klinik Psikofarmakoloji Bulteni. 2007;17(4).
3. 3. Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991;148(6):705-13.
4. 4. Dunkley E, Isbister G, Sibbritt D, Dawson A, Whyte I. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. Qjm. 2003;96(9):635-42.
5. 5. Radomski J, Dursun S, Reveley M, Kutcher S. An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria. Medical hypotheses. 2000;55(3):218-24.
6. 6. Coleman JJ, Pontefract SK. Adverse drug reactions. Clinical Medicine. 2016;16(5):481.
7. 7. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts E, et al. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology & Therapeutics. 1981;30(2):239-45.
8. 8. Karunatilake H, Buckley NA. Serotonin syndrome induced by fluvoxamine and oxycodone. Annals of Pharmacotherapy. 2006;40(1):155-7.

9. 9. Ailawadhi S, Sung KW, Carlson L, Baer M. Serotonin syndrome caused by interaction between citalopram and fentanyl. Journal of clinical pharmacy and therapeutics. 2007;32(2):199- 202.
10. 10. Pan J-J, Shen WW. Serotonin syndrome induced by low-dose venlafaxine. Annals of Pharmacotherapy. 2003;37(2):209-11.
11. 11. Inaguma D, Kitagawa W, Hayashi H, Kanoh T, Kurata K, Kumon S. Three cases of severe hyponatremia under taking selective serotonin reuptake inhibitor (SSRI). Nihon Jinzo Gakkai Shi. 2000;42(8):644-8.
12. 12. Kirby D, Harrigan S, Ames D. Hyponatraemia in elderly psychiatric patients treated with selective serotonin reuptake inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit. International journal of geriatric psychiatry. 2002;17(3):231-7.
13. 13. Oruch R, Pryme IF, Engelsen BA, Lund A. Neuroleptic malignant syndrome: an easily overlooked neurologic emergency. Neuropsychiatric disease and treatment. 2017:161-75.
14. 14. Bartlett D. Drug-induced serotonin syndrome. Critical care nurse. 2017;37(1):49-54.
15. 15. Kan R, Endou M, Unno Y. A case of serotonin syndrome following minimum doses of sertraline. Seishin Shinkeigaku Zasshi=Psychiatria et Neurologia Japonica. 2009;111(9):1041-6.
16. 16. Gelener P, Gorgulu U, Kutlu G, Ucler S, Inan LE. Serotonin syndrome due to duloxetine. Clinical Neuropharmacology. 2011;34(3):127-8.
17. 17. Öztürk N, Ezgi K, Sözeri-Varma G, Değirmenci E. Düşük doz essitalopram ile serotonin sendromu. Journal of Mood Disorders. 2013;3(1):37-40.
18. 18. Stahl SM. Prescriber's guide: Antidepressants: Stahl's essential psychopharmacology: Cambridge University Press; 2017.
19. 19. George TP, Godleski LS. Possible serotonin syndrome with trazodone addition to fluoxetine. Biological psychiatry. 1996;39(5):384-5.
20. 20. Rao R. Serotonin syndrome associated with trazodone. International journal of geriatric psychiatry. 1997;12(1):129-30.
21. 21. Reeves RR, Bullen JA. Serotonin syndrome produced by paroxetine and low-dose trazodone. Psychosomatics: Journal of Consultation and Liaison Psychiatry. 1995.